Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTNNB1 | P35222 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 6/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30682789 | 0.91 | LMNA (0.55) | CTNNB1LMNACES2CES1SMN1; SMN2 | |
| SCHEMBL9284330 | 0.91 | CTNNB1 (0.47) | CTNNB1LMNACES2CES1SMN1; SMN2 | |
| SCHEMBL10825926 | 0.84 | CTNNB1 (0.62) | CTNNB1LMNASMN1; SMN2L3MBTL1MAPK1 | |
| SCHEMBL277654 | 0.81 | HPGD (0.56) | LMNACES2CES1MAPK1RAB9A | |
| SCHEMBL124171 | 0.81 | LMNA (0.52) | LMNACES2CES1L3MBTL1MAPK1 | |
| Methoxymethane SCHEMBL5593577 | 0.80 | HPGD (0.55) | LMNACES2CES1MAPK1RAB9A | |
| Diphenylether SCHEMBL28786730 | 0.80 | LMNA (0.46) | LMNACES2CES1SMN1; SMN2MAPK1 | |
| SCHEMBL3362510 | 0.79 | CTNNB1 (0.61) | CTNNB1LMNASMN1; SMN2L3MBTL1MAPK1 | |
| SCHEMBL10137793 | 0.79 | CTNNB1 (0.61) | CTNNB1LMNASMN1; SMN2L3MBTL1RAB9A | |
| SCHEMBL11896596 | 0.79 | LMNA (0.49) | LMNACES2CES1SMN1; SMN2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0340216-B1 | COMPOSITIONS INCLUDING HERBICIDAL COMBINATIONS OF THE GLYPHOSATE TYPE AND THE PHENOXYBENZOIC TYPE | RHONE-POULENC AGROCHIMIE (FR) | 1993-05-19 | — | — | EP | claimed |
| EP-0089538-B1 | OPTICALLY ACTIVE DERIVATIVES OF PHENOXY-BENZOIC ACID, PROCESS FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES | BAYER AG (DE) | 1985-01-30 | — | — | EP | claimed |
| WO-2024079245-A1 | RIDINILAZOLE FOR TREATING CLOSTRIDIUM DIFFICILE | SUMMIT (OXFORD) LIMITED (GB) | 2024-04-18 | — | — | WO | disclosed |
| WO-2023213878-A1 | SOLID TABLET DOSAGE FORM OF RIDINILAZOLE | SUMMIT (OXFORD) LIMITED (GB) | 2023-11-09 | — | — | WO | disclosed |
| EP-3766527-B1 | OSTEOINDUCTIVE BONE IMPLANT AND METHOD FOR ITS IRRADIATION WITH ELECTRON BEAMS | WARSAW ORTHOPEDIC INC (US) | 2023-09-13 | — | — | EP | disclosed |
| WO-2023105491-A1 | 5,6,7,8-TETRAHYDRO-2,6-NAPHTHYRIDINE DERIVATIVES AS CANCER THERAPEUTICS | VRISE THERAPEUTICS, INC. (US) | 2023-06-15 | — | — | WO | disclosed |
| WO-2022153056-A1 | PROCESS FOR PURIFYING RIDINILAZOLE | SUMMIT (OXFORD) LIMITED (GB) | 2022-07-21 | — | — | WO | disclosed |
| EP-3999502-A1 | PROCESS FOR THE PREPARATION OF RIDINILAZOLE AND CRYSTALLINE FORMS THEREOF | Summit (Oxford) Limited (GB) | 2022-05-25 | — | — | EP | disclosed |
| EP-3367973-B1 | IMPLANTS HAVING A DRUG LOAD OF AN OXYSTEROL AND METHODS OF USE | WARSAW ORTHOPEDIC INC (US) | 2022-03-23 | — | — | EP | disclosed |
| US-9987290-B2 | Methods for the separation and detection of an oxysterol | WARSAW ORTHOPEDIC, INC. (US) | 2018-06-05 | — | — | US | disclosed |
| US-20170273990-A1 | METHODS FOR THE SEPARATION AND DETECTION OF AN OXYSTEROL | WARSAW ORTHOPEDIC, INC. | 2017-09-28 | — | — | US | disclosed |
| EP-0341607-A2 | Anticoagulant peptide alcohols | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-11-15 | — | — | EP | disclosed |
| EP-0340216-A1 | COMPOSITIONS INCLUDING HERBICIDAL COMBINATIONS OF THE GLYPHOSATE TYPE AND THE PHENOXYBENZOIC TYPE | RHONE-POULENC AGROCHIMIE (FR) | 1989-11-08 | — | — | EP | disclosed |
| EP-0320983-A2 | Piperidinyl compounds | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-06-21 | — | — | EP | disclosed |
| WO-1989003641-A1 | COMPOSITIONS INCLUDING HERBICIDAL COMBINATIONS OF THE GLYPHOSATE TYPE AND THE PHENOXYBENZOIC TYPE | RHONE POULENC AGROCHIMIE (FR) | 1989-05-05 | — | — | WO | disclosed |
| EP-0297534-A2 | Castanospermine esters and glycosides | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-01-04 | — | — | EP | disclosed |
| CN-87107479-A | Herbicidal composition based on a herbicide of the glyphosate type and on a herbicide of the phenoxybenzoic type and method for controlling weeds using these compositions | — | 1988-08-10 | — | — | CN | disclosed |
| CN-87107479-A | Herbicidal composition based on a herbicide of the glyphosate type and on a herbicide of the phenoxybenzoic type and method for controlling weeds using these compositions | — | 1988-08-10 | — | — | CN | disclosed |
| EP-0255794-A1 | Process for preparing an aromatic acid | RHONE-POULENC CHIMIE (FR) | 1988-02-10 | — | — | EP | disclosed |
| US-4242121-A | USING A PHENOXYBENZOIC ACID, ITS ESTER OR SALT | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170273990-A1 | METHODS FOR THE SEPARATION AND DETECTION OF AN OXYSTEROL | OSBP2, NR1H3, OSBP | CTNNB1 1900/4885LMNA 554/4885CES2 2033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.